These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2185492)

  • 21. [Cyclosporin A. Inhibitory effect on T lymphocytes].
    Jørgensen PF; Bruserud O
    Tidsskr Nor Laegeforen; 1986 Aug; 106(24):1941-2. PubMed ID: 3490706
    [No Abstract]   [Full Text] [Related]  

  • 22. [T lymphocyte activation and its inhibition by cyclosporin A].
    Ryffel B
    Schweiz Rundsch Med Prax; 1987 May; 76(22):615-6. PubMed ID: 3497420
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
    Redelman D
    Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the biological activity of cyclosporine metabolites using the human JURKAT cell line.
    Freed BM; Stevens C; Brooks C; Cramer S; Lempert N; Rosano TG
    Transplant Proc; 1991 Feb; 23(1 Pt 2):980-1. PubMed ID: 1989352
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1027-8. PubMed ID: 1989147
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclosporine and the immune response: basic aspects.
    Hess AD; Colombani PM; Esa AH
    Crit Rev Immunol; 1986; 6(2):123-49. PubMed ID: 2942335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine A allows the expression of high affinity interleukin 2 binding sites on anti-T-cell antibody activated human T lymphocytes.
    Ryffel B; Müller S; Foxwell B
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1199-201. PubMed ID: 3079016
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression.
    Reed JC; Abidi AH; Alpers JD; Hoover RG; Robb RJ; Nowell PC
    J Immunol; 1986 Jul; 137(1):150-4. PubMed ID: 3011905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine inhibits macrophage-mediated antigen presentation.
    Palay DA; Cluff CW; Wentworth PA; Ziegler HK
    J Immunol; 1986 Jun; 136(12):4348-53. PubMed ID: 3486899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effects of cyclosporines A and G on activation of an autoimmune T cell line.
    Caspi RR; McAllister CG; Gery I; Borel J; Hiestand P; Nussenblatt RB
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):110-4. PubMed ID: 2966473
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanism of action of cyclosporin A in vivo. I. Cyclosporin A fails to inhibit T lymphocyte activation in response to alloantigens.
    Kroczek RA; Black CD; Barbet J; Shevach EM
    J Immunol; 1987 Dec; 139(11):3597-603. PubMed ID: 3119712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine sensitivity of human alloreactive T lymphocytes depends on the strength of the allogeneic stimulus.
    Kunkl A; Fenoglio D; Manca F; Caltabellotta M; Barocci S; Carozzi S; Valente U; Gessaga M; Celada F
    Transplant Proc; 1987 Feb; 19(1 Pt 1):262. PubMed ID: 2978901
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
    Lillehoj HS; Malek TR; Shevach EM
    J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S; Suzuki G; Kawase Y; Takaku F
    J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of cyclosporine on canine lymphocyte activity.
    Payne JA; Herrod HG; Buice R
    J Clin Lab Immunol; 1986 Aug; 20(4):177-81. PubMed ID: 3531520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble inhibitors of T lymphocyte proliferation: tools for dissecting pathways of T cell activation.
    Reed JC; Nowell PC
    Immunol Res; 1988; 7(2):93-112. PubMed ID: 3134500
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
    Havele C; Paetkau V
    J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinically used concentrations of cyclosporine A only partially inhibit interferon-gamma production by activated T lymphocytes.
    Buurman WA; Daemen AJ; van der Linden CJ; Kootstra G
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1193. PubMed ID: 3152624
    [No Abstract]   [Full Text] [Related]  

  • 39. Additive effect of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):240-4. PubMed ID: 2966479
    [No Abstract]   [Full Text] [Related]  

  • 40. Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction.
    Orosz CG; Adams PW; Ferguson RM
    Transplantation; 1988 Aug; 46(2 Suppl):73S-79S. PubMed ID: 2970141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.